IP Library Granted Patent US 9,144,582
Granted Patent B2
US 9,144,582 · App. 14/136,263 · Granted Sep 29, 2015

Granulated material mixture comprising two different granulated materials for artificial callus distraction

Inventor: Domonkos Horvath (Jestetten, DE)
Assignee: CELGEN3D AG
A61K33/42A61K9/1623A61K9/1652A61L27/12A61L27/20A61L27/425A61L27/46A61L27/50A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,144,582
App. No.
14/136,263
Granted
Sep 29, 2015
Kind
B2
Abstract

A granulate mixture suitable for regenerating a bone contains at least one expandable particle and at least one nondeformable particle. The at least one expandable particle contains a swelling agent. The swelling is enclosed by a biodegradable sheathing or be a biodegradable casing. Three-dimensional callus distraction may be accomplished by introducing the granulated mixture into a bone defect.

Claims (24)

1. A granulate mixture suitable for regenerating a bone comprising a plurality of nondeformable particles and a plurality of expandable particles;

wherein the nondeformable particles of the plurality of nondeformable particles have a particle size of 0.01 mm to 10 mm.

2. The granulate mixture according to claim 1 , wherein a mixing ratio of the plurality of expandable particles to the plurality of nondeformable particles in the granulate mixture is 1:99 to 99:1, relative to a number of particles.

3. The granulate mixture according to claim 1 , wherein the plurality of expandable particles is composed of a swelling agent.

4. The granulate mixture according to claim 3 , wherein the swelling agent is a hydrogel.

5. The granulate mixture according to claim 3 , wherein the swelling agent expands as a result of absorption of a liquid selected from a group consisting of: a liquid containing biomolecules, cells, and a combination thereof.

6. The granulate mixture according to claim 5 , wherein the liquid is blood.

7. The granulate mixture according to claim 3 , wherein the swelling agent for the plurality of expandable particles is composed of a polysaccharide.

8. The granulate mixture according to claim 3 , wherein the swelling agent for the plurality of expandable particles is composed of a glucosamine.

9. The granulate mixture according to claim 1 , wherein the expandable particles of the plurality of expandable particles have a particle size of 0.0001 mm to 10 mm.

10. The granulate mixture according to claim 1 , wherein the expandable particles of the plurality of expandable particles have a particle size of 0.1 mm to 10 mm.

11. The granulate mixture according to claim 1 , wherein the expandable particles of the plurality of expandable particles are present in at least two different particle sizes.

12. The granulate mixture according to claim 1 , wherein the plurality of nondeformable particles contains a bone replacement material.

13. The granulate mixture according to claim 1 , wherein the plurality of nondeformable particles contains hydroxyapatite and/or tricalcium phosphate.

14. The granulate mixture according to claim 1 , wherein the nondeformable particles of the plurality of nondeformable particles have a particle size of 0.1 mm to 10 mm.

15. A granulate mixture suitable for regenerating a bone comprising:

a plurality of nondeformable particles; and

a plurality of expandable particles having a swelling agent, wherein the swelling agent expands as a result of absorption of a liquid selected from a group consisting of: a liquid containing biomolecules, cells, and a combination thereof;

wherein a mixing ratio of the plurality of expandable particles to the plurality of nondeformable particles in the granulate mixture is 1:99 to 99:1, relative to a number of particles;

wherein the expandable particles of the plurality of expandable particles have a article size of 0.0001 mm to 10 mm, and further wherein the nondeformable particles of the plurality of nondeformable particles have a particle size of 0.01 to 10 mm.

16. The granulate mixture according to claim 15 , wherein the swelling agent is selected from a group consisting of a polysaccharide and a glucosamine.

17. The granulate mixture according to claim 15 , wherein the plurality of nondeformable particles contains hydroxyapatite and/or tricalcium phosphate.

18. The granulate mixture according to claim 15 , wherein the plurality of nondeformable particles contains a bone replacement material.

19. The granulate mixture according to claim 15 , wherein the expandable particles of the plurality of expandable particles are present in at least two different particle sizes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2014
From: HORVATH, DOMONKOS
To: CELGEN3D AG C/O LACMONT AG
Reel/Frame 032635/0176 →
Priority Claims (1)
DE 10 2009 042 493 · Sep 14, 2009 · national
Continuity (2)
Division 13395937
Related Publication 20140105988A1 · Apr 17, 2014